From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. (February 2021)

Record Type:: Journal Article
Title:: From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. (February 2021)
Main Title:: From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Authors:: Verma, Ajay M
Patel, Anusha
Subramanian, Sreedhar
Smith, Philip J
Abstract:
Is Part Of:: Lancet gastroenterology and hepatology. Volume 6:Number 2(2021)
Journal:: Lancet gastroenterology and hepatology
Issue:: Volume 6:Number 2(2021)
Issue Display:: Volume 6, Issue 2 (2021)
Year:: 2021
Volume:: 6
Issue:: 2
Issue Sort Value:: 2021-0006-0002-0000
Page Start:: 88
Page End:: 89
Publication Date:: 2021-02
Journal URLs:: http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2468-1253(20)30392-7 ↗
Languages:: English
ISSNs:: 2468-1253
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.081000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 15495.xml